Q2 FY2026 · ended Jun 30, 2026 · Revenue $36.93M, +2.6% YoY · Filed Aug 4, 2026
Infusystem Holdings, Inc (INFU) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $36.9 million and net income of $3.2 million. Free cash flow was $6.7 million. As of Jun 30, 2026 it held $964,000 in cash and investments and $24.5 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- INFU (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochester Hills, MI
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1337013
- Former names
- HAPC, Inc. (until Oct 30, 2007); Healthcare Acquisition Partners Corp. (until Apr 25, 2006)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $36.9M | $33.7M | $36.2M | $36.5M | $36.0M |
| Operating income | $4.2M | $1.6M | $3.7M | $3.8M | $3.8M |
| Net income | $3.2M | $1.0M | $2.0M | $2.3M | $2.6M |
| Diluted EPS | $0.15 | $0.05 | $0.10 | $0.11 | $0.12 |
| Operating cash flow | $6.8M | $970,000 | $7.1M | $8.5M | $7.0M |
| Free cash flow | $6.7M | $813,000 | $7.0M | $8.4M | $6.8M |
| Total assets | $97.7M | $98.7M | $100.6M | $98.9M | $100.8M |
| Total liabilities | $38.6M | $39.9M | $43.2M | $43.4M | $46.3M |
| Stockholders' equity | $59.1M | $58.7M | $57.3M | $55.5M | $54.5M |
| Cash and investments | $964,000 | $2.1M | $3.2M | $955,000 | $720,000 |
| Total debt | $24.5M | $24.1M | $24.4M | $26.1M | $31.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
All 1001 Infusystem Holdings, Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.